Metrics as of 10/13/2026, 11:19 PM (Berlin time), refresh in progress.
UFP Technologies Stock
UFP Technologies, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Mitchell C. Rock
- Employees
- 4,846
- Market cap
- $2.2 B
- IPO
- 17/12/1993
- Web
- www.ufpt.com
UFP Technologies, Inc. is a healthcare company operating within the medical devices industry. Established in 1963 and headquartered in Newburyport, the company specializes in the engineering and custom fabrication of components, subassemblies, finished products, and packaging, primarily utilizing advanced foams,…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
UFP Technologies stock: price history
1D
-2.3%
1W
-1.8%
1M
+3.4%
6M
+46.5%
YTD
+29.5%
1Y
+44.2%
2Y
-8.4%
5Y
+350.4%
10Y
+1,002.2%
Next earnings date
Next earnings date
02/11/2026 (in 16 days)
Volatility around earnings
~86% stronger price swings than usual
UFP Technologies stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Ask the agents about UFP Technologies
Analyst assessment of UFP Technologies
PRICE TARGET LOW
US$252.00
CONSENSUS
US$298.00
MEDIAN
US$298.00
PRICE TARGET HIGH
US$344.00
0
STRONG BUY
2
BUY
0
HOLD
0
SELL
0
STRONG SELL
2
TOTAL · Buy
As of: 06/08/2025
UFP Technologies stock metrics
P/E
30.72
P/B
4.81
EV/EBITDA
20.26
RETURN ON EQUITY
4.5%
NET MARGIN
12.0%
DEBT/EQUITY
0.29
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
96.0%
FLOAT SHARES
7,428,483
AVG. DAILY VOLUME (30D)
112,499
Insider transactions (SEC)
KOZIN MARC D
KOZIN MARC D
Hudson Symeria
FELDMANN CYNTHIA L
Hudson Symeria
Institutional holders
Smart Money
Register for free
Register now to see which funds are invested
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Comparable stocks
Frequently asked questions about UFP Technologies stock
What does UFP Technologies do?
UFP Technologies, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Mitchell C. Rock, the company employs around 4,846 people.
The IPO was on 17/12/1993; the stock trades on NASDAQ under the ticker UFPT.
What do analysts say about UFP Technologies stock?
2 analysts rate the stock, the consensus is Buy (as of 06/08/2025).
The average price target is US$298.00, ranging from US$252.00 to US$344.00, with a median of US$298.00.
This is an external assessment, not a statement by Market Jury.
When does UFP Technologies report next?
The next earnings date is 02/11/2026.
Around past earnings, price swings were roughly 86% stronger than usual.
Does UFP Technologies pay a dividend?
No, UFP Technologies currently does not pay a dividend.
Which stocks are comparable to UFP Technologies?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get UFP Technologies stock analyzed?
Clicking "Analyze stock" lets five strategies assess UFP Technologies against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.